Skip to main content

Table 1 CPA and Non-CPA patient characteristics

From: Prospective study of the serum Aspergillus-specific IgG, IgA and IgM assays for chronic pulmonary aspergillosis diagnosis

Characteristic CPA patients (n = 42) Non-CPA patients (n = 60)
Male gender 20 (47.6%) 37 (61.7%)
Age (years) (mean ± SD) 54.6 ± 16.8 52.7 ± 18.1
Underlying lung diseases
 Bronchiectasis 12 (28.6%) 18 (30.0%)
 COPD 8 (19.0%) 10 (16.7%)
 Emphysema 6 (14.3%) 1 (1.7%)
 Previous tuberculosis 3 (7.1%) 4 (6.7%)
 Interstitial pneumonia 2 (4.8%) 2 (3.3%)
 Asthma 2 (4.8%) 8 (13.3%)
 Pulmonary embolism 2 (4.8%) 0
 Prior pneumonia 2 (4.8%) 5 (8.3%)
 Chronic bronchitis 2 (4.8%) 8 (13.3%)
 Pulmonary sarcoidosis 1 (2.4%) 2 (3.3%)
 Eosinophilic pneumonia 1 (2.4%) 0
 No underlying pulmonary diseases 4 (9.5%) 5 (8.3%)
Underlying systemic diseases
 Diabetes mellitus 6 (14.3%) 9 (15.0%)
 Heart failure 5 (11.9%) 8 (13.3%)
 Rheumatic disease 5 (11.9%) 3 (5.0%)
 Chronic renal failure 3 (7.1%) 4 (6.7%)
Chronic pulmonary or systemic symptoms
 Cough 32 (76.2%) 45 (75.0%)
 Sputum 30 (71.4%) 38 (63.3%)
 Fever 19 (45.2%) 34 (56.7%)
 Dyspnea 17 (40.5%) 30 (50.0%)
 Hemoptysis 11 (26.2%) 9 (15.0%)
 Chest pain 2 (4.8%) 2 (3.3%)
Chest CT findings
 Bronchiectasis 12 (28.6%) 18 (30.0%)
 Consolidation 8 (19.0%) 9 (15.0%)
 Cavitation 5 (11.9%) 5 (8.3%)
 Pleural effusion 4 (9.5%) 8 (13.3%)
 Nodules 4 (9.5%) 19 (31.7%)
 Bullae of lung 3 (7.1%) 1 (1.7%)
 Fibrotic changes 3 (7.1%) 5 (8.3%)
 Pleural thickening 3 (7.1%) 3 (5.0%)
 Fungal ball 2 (4.8%) 0
 Mass 2 (4.8%) 6 (10.0%)
 Halo sign 2 (4.8%) 0
 Air crescent sign 1 (2.4%) 0
  1. COPD chronic obstructive pulmonary disease, CPA chronic pulmonary aspergillosis, CT computed tomography